MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia

Phase 2
Terminated
Conditions
Chronic Lymphocytic Leukemia
Interventions
First Posted Date
2011-11-04
Last Posted Date
2014-10-23
Lead Sponsor
Yale University
Target Recruit Count
2
Registration Number
NCT01465230
Locations
🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

Using Capnography to Reduce Hypoxia During Pediatric Sedation

Not Applicable
Completed
Conditions
Hypoventilation
Hypoxia
Interventions
Device: Nellcor NPB-70 Capnograph
First Posted Date
2011-11-02
Last Posted Date
2018-01-11
Lead Sponsor
Yale University
Target Recruit Count
167
Registration Number
NCT01463527
Locations
🇺🇸

Yale-New Haven Children's Hospital, New Haven, Connecticut, United States

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

Not Applicable
Completed
Conditions
Hypoglycemia
Interventions
First Posted Date
2011-10-31
Last Posted Date
2016-02-18
Lead Sponsor
Yale University
Target Recruit Count
17
Registration Number
NCT01462227
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Minding the Baby Home Visiting: Program Evaluation

Not Applicable
Completed
Conditions
Child Maltreatment
Maternal Sensitivity
Attachment
Infant Health
Interventions
Behavioral: Minding the Baby Home Visiting Program
First Posted Date
2011-10-24
Last Posted Date
2018-01-17
Lead Sponsor
Yale University
Target Recruit Count
151
Registration Number
NCT01458145
Locations
🇺🇸

Fair Haven Community Health Center, New Haven, Connecticut, United States

🇺🇸

Cornell Scott Hill Health Center, New Haven, Connecticut, United States

Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

Phase 1
Completed
Conditions
Cholangitis, Sclerosing
Interventions
Drug: Oral all-trans retinoic acid (ATRA)
First Posted Date
2011-10-20
Last Posted Date
2016-07-14
Lead Sponsor
Yale University
Target Recruit Count
19
Registration Number
NCT01456468
Locations
🇺🇸

Yale University School of Medicine - 333 Cedar St - 1080 LMP, New Haven, Connecticut, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Procedure: Shave margins
Procedure: No Shave Margins
First Posted Date
2011-10-14
Last Posted Date
2021-01-26
Lead Sponsor
Yale University
Target Recruit Count
251
Registration Number
NCT01452399
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure

Not Applicable
Completed
Conditions
Stroke
Transient Ischemic Attack
Interventions
Behavioral: Enhanced CPAP Intervention
Device: Standard CPAP Intervention
First Posted Date
2011-10-05
Last Posted Date
2020-11-18
Lead Sponsor
Yale University
Target Recruit Count
255
Registration Number
NCT01446913
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

🇺🇸

University of Indiana, Indianapolis, Indiana, United States

Computer Based Training in Cognitive Behavioral Therapy Web-based

Phase 1
Completed
Conditions
Substance Abuse
Interventions
Behavioral: CBT4CBT
Behavioral: Individual clinician-provided CBT
Behavioral: Standard Treatment As Usual (TAU)
First Posted Date
2011-09-28
Last Posted Date
2020-03-06
Lead Sponsor
Yale University
Target Recruit Count
164
Registration Number
NCT01442597
Locations
🇺🇸

Substance Abuse Treatment Unit (SATU), New Haven, Connecticut, United States

Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease

Phase 2
Withdrawn
Conditions
Paget's Disease of the Vulva
Interventions
First Posted Date
2011-09-01
Last Posted Date
2014-06-16
Lead Sponsor
Yale University
Registration Number
NCT01427244
Locations
🇺🇸

Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States

A Smoking Cessation Treatment for Adult Women

Phase 1
Completed
Conditions
Nicotine Dependence
Interventions
Behavioral: Tailored treatment
Behavioral: Standard Treatment
First Posted Date
2011-08-23
Last Posted Date
2020-04-20
Lead Sponsor
Yale University
Target Recruit Count
28
Registration Number
NCT01422239
Locations
🇺🇸

Yale University School of Medicine, Department of Psychiatry, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath